Get the Stockscreener App
19.88
3.40%
-0.70
After Hours:
19.72
-0.16
-0.80%
Overview
News
Price History
Option Chain
Financials
Why CC Down?
Discussions
Forecast
Dividend History
Chemours Company stock is traded at $19.88, with a volume of 2.13M.
It is down -3.40% in the last 24 hours and up +1.58% over the past month.
The Chemours Co is a global provider of chemicals. It delivers customized solutions with a wide range of industrial and specialty chemicals products for various markets including coatings, plastics, refrigeration, air conditioning, etc. The company's operating segments include Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. It generates maximum revenue from the Titanium Technologies segment. The Titanium Technologies segment is a producer of TiO2 pigment, a premium white pigment used to deliver whiteness, brightness, opacity, durability, efficiency, and protection across a variety of applications. Geographically, the company derives a majority of its revenue from North America.
See More
Previous Close:
$20.58
Open:
$20.14
24h Volume:
2.13M
Relative Volume:
1.44
Market Cap:
$3.03B
Revenue:
$5.84B
Net Income/Loss:
$-330.00M
P/E Ratio:
-9.8905
EPS:
-2.01
Net Cash Flow:
$9.00M
1W Performance:
+8.69%
1M Performance:
+1.58%
6M Performance:
-25.18%
1Y Performance:
-22.59%
1-Day Range:
$19.70
$20.45
1-Week Range:
$17.64
$21.25
52-Week Range:
$15.10
$32.70
Chemours Company Stock (CC) Company Profile
Name
Chemours Company
Sector
Industry
Phone
302 773 1000
Address
1007 MARKET STREET, WILMINGTON, DE
Chemours Company Stock (CC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-01-23 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Jun-22-23 | Downgrade | BofA Securities | Buy → Neutral |
| Jan-24-23 | Upgrade | UBS | Neutral → Buy |
| Jan-11-23 | Upgrade | BofA Securities | Neutral → Buy |
| Jan-10-23 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Nov-01-22 | Initiated | Credit Suisse | Underperform |
| Oct-13-22 | Initiated | Goldman | Neutral |
| Oct-05-22 | Downgrade | Argus | Buy → Hold |
| Jun-14-22 | Downgrade | BofA Securities | Buy → Neutral |
| Jun-10-21 | Initiated | Wolfe Research | Outperform |
| Jun-09-21 | Upgrade | Goldman | Neutral → Buy |
| May-20-21 | Initiated | BofA Securities | Buy |
| May-06-21 | Upgrade | Argus | Hold → Buy |
| Jan-08-21 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Dec-04-20 | Downgrade | Barclays | Overweight → Equal Weight |
| Nov-30-20 | Initiated | Alembic Global Advisors | Overweight |
| Mar-23-20 | Downgrade | Jefferies | Buy → Hold |
| Feb-14-20 | Upgrade | CFRA | Buy → Strong Buy |
| Nov-06-19 | Upgrade | CFRA | Hold → Buy |
| Aug-20-19 | Upgrade | Susquehanna | Neutral → Positive |
| Aug-09-19 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Aug-06-19 | Downgrade | Argus | Buy → Hold |
| Aug-05-19 | Downgrade | SunTrust | Buy → Hold |
| Jul-12-19 | Downgrade | Citigroup | Buy → Neutral |
| May-06-19 | Downgrade | JP Morgan | Overweight → Neutral |
| Apr-15-19 | Upgrade | SunTrust | Hold → Buy |
| Feb-19-19 | Downgrade | Susquehanna | Positive → Neutral |
| Jan-08-19 | Initiated | HSBC Securities | Buy |
| Jan-04-19 | Upgrade | Citigroup | Neutral → Buy |
| Nov-02-18 | Downgrade | Citigroup | Buy → Neutral |
| Jul-18-18 | Initiated | RBC Capital Mkts | Outperform |
| Jan-30-18 | Initiated | Morgan Stanley | Equal-Weight |
| Dec-06-17 | Downgrade | Goldman | Buy → Neutral |
| Aug-07-17 | Upgrade | UBS | Sell → Neutral |
View All
Chemours Company Stock (CC) Latest News
Chemours (NYSE:CC) Issues Quarterly Earnings Results, Beats Expectations By $0.08 EPS - MarketBeat
Morgan Stanley Issues Pessimistic Forecast for Chemours (NYSE:CC) Stock Price - MarketBeat
Chemours (NYSE:CC) Price Target Raised to $23.00 - MarketBeat
What Analysts Are Saying About Chemours Stock - Benzinga
The Chemours Company (NYSE:CC) Q3 2024 Earnings Call Transcript - Insider Monkey
Chemours price target lowered to $25 from $30 at Morgan Stanley - TipRanks
Chemours Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags - Simply Wall St
Chemours price target raised to $23 from $21 at Barclays - TipRanks
Should You Investigate The Chemours Company (NYSE:CC) At US$20.58? - Yahoo Finance
The Chemours Co (CC) Q3 2024 Earnings Call Highlights: Navigatin - GuruFocus.com
The Chemours Co (CC) Q3 2024 Earnings Call Highlights: Navigating Challenges with Strategic ... - Yahoo Finance
Chemours Reports Q3 2024 Results and Strategic Update - TipRanks
Chemours (CC) Stabilizes with Strong Q3 Results and Record Sales in TSS Segment - GuruFocus.com
Chemours (CC) Q3 2024 Earnings Call Transcript - The Motley Fool
Chemours (NYSE:CC) Shares Gap UpWhat's Next? - MarketBeat
The Chemours Co (CC) Stock Price Up 16.44% on Nov 4 - GuruFocus.com
Chemours Washington Works Nature Trail Dedicates Outdoor Classroom to U.S. Senator Joe Manchin, III - 3BL Media
Update: Chemours halts $200m hydrogen membrane manufacturing expansion - H2 View
Chemours's stock jumps on quarterly revenue growth (NYSE:CC) - Seeking Alpha
Chemours Surges 17% On The Recent Q3 Results - GuruFocus.com
Chemours Adjusts Hydrogen Investment Strategy Amid Market Slowdown - FuelCellsWorks
Chemours (CC) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates - Yahoo Finance
Chemours's stock jumps on quarterly revenue growth - MSN
CCThe Chemours Company Latest Stock News & Market Updates - StockTitan
Chemours Swings to 3Q Loss But Sales Grow, Beating Market Views - MarketWatch
Chemours (CC) Q3 Earnings and Revenues Top Estimates - Yahoo Finance
Chemours Co earnings beat by $0.11, revenue topped estimates - Investing.com
Chemours: Q3 Earnings Snapshot - The Advocate
Chemours sees Q4 revenue down in the mid to high-single digits sequentially - TipRanks
Chemours stock rises as Q3 earnings and revenue top estimates - Investing.com India
The Chemours Company Reports Third Quarter 2024 Results and Outlines Refreshed Corporate Strategy - The Bakersfield Californian
The Chemours Company Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
The Chemours Co (FRA:2CU) Intrinsic Value: Projected FCF : €16.16 (As of Nov. 03, 2024) - GuruFocus.com
Private Management Group Inc. Purchases 329,037 Shares of The Chemours Company (NYSE:CC) - MarketBeat
Can The Chemours Company's (NYSE:CC) ROE Continue To Surpass The Industry Average? - Simply Wall St
How to Take Advantage of moves in (CC) - Stock Traders Daily
The Chemours Co (LTS:0HWG) Earnings Yield % : 4.12% (As of Oct. 30, 2024) - GuruFocus.com
Long-Term Investors in Chemours Company (NYSE: CC) shares - openPR
Nafion Market Is Booming So Rapidly | Chemours, 3M, Dongyue Group - openPR
Earnings Preview: Chemours (CC) Q3 Earnings Expected to Decline - Yahoo Finance
Europe Refrigerant Market: Size, Share, Demand, Trends, - openPR
Chemours (CC) Set to Announce Earnings on Monday - MarketBeat
Chemours cuts ribbon on new polymer production line - MSN
THE CHEMOURS COMPANY INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of The Chemours CompanyCC - Business Wire
Process Technology Spring InternshipThe Chemours Company - Built In
Mining Engineer Summer InternThe Chemours Company - Built In
The Chemours Company (NYSE:CC) Declares Quarterly Dividend of $0.25 - MarketBeat
Fluoropolymers Market Report: Research Insights and Growth - openPR
Chemours Washington Works facility is expanding production - WTAP
Chemours Announces Fourth Quarter Dividend - The Bakersfield Californian
State sets temporary allowable PFAS limits in groundwater - NC Newsline
Chemours Company Stock (CC) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.54%
0.17%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):